MM09 MG01
Alternative Names: MM09-MG01Latest Information Update: 17 Sep 2021
At a glance
- Originator Immunotek SL
- Class Allergens; Allergy immunotherapies; Antiallergics
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase III Allergic rhinitis; Asthma
Most Recent Events
- 30 Apr 2021 Phase-III clinical trials in Allergic rhinitis (In adults, In the elderly) in Spain (SC) (NCT04874714)
- 30 Apr 2021 Phase-III clinical trials in Asthma (In adults, In the elderly) in Spain (SC) (NCT04874714)
- 30 Apr 2021 Preclinical trials in Allergic rhinitis in Spain (SC), prior to April 2021